CAPTRUST Financial Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420K | Buy |
+36,279
| New | +$420K | ﹤0.01% | 1839 |
|
|
2024
Q1 | – | Sell |
-4,488
| Closed | -$251K | – | 2643 |
|
|
2023
Q4 | $251K | Buy |
+4,488
| New | +$251K | ﹤0.01% | 2228 |
|
|
2022
Q3 | – | Sell |
-232
| Closed | -$10K | – | 3927 |
|
|
2022
Q2 | $10K | Sell |
232
-1,404
| -86% | -$60.5K | ﹤0.01% | 3757 |
|
|
2022
Q1 | $124K | Buy |
1,636
+1,217
| +290% | +$92.2K | ﹤0.01% | 2107 |
|
|
2021
Q4 | $62K | Sell |
419
-150
| -26% | -$22.2K | ﹤0.01% | 2512 |
|
|
2021
Q3 | $83K | Sell |
569
-25
| -4% | -$3.65K | ﹤0.01% | 2223 |
|
|
2021
Q2 | $116K | Sell |
594
-41
| -6% | -$8.01K | ﹤0.01% | 1913 |
|
|
2021
Q1 | $115K | Buy |
635
+435
| +218% | +$78.8K | ﹤0.01% | 1856 |
|
|
2020
Q4 | $28K | Hold |
200
| – | – | ﹤0.01% | 2102 |
|
|
2020
Q3 | $25K | Hold |
200
| – | – | ﹤0.01% | 1886 |
|
|
2020
Q2 | $18K | Buy |
+200
| New | +$18K | ﹤0.01% | 1987 |
|